Clinical Trial Update: Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content

View source ↗

Summary

This clinical trial investigates how gender-affirming hormone therapy affects myocardial mass, cardiac function, and fat content in the heart, liver, and pancre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gender Dysphoria

Drugs mentioned

• ESTRADIOL (Estradiol)
• Spironolactone (spironolactone)
• TESTOSTERONE (testosterone)

Snippet

Sponsor: Medical University of Vienna | Conditions: Gender Dysphoria, Hormone Therapy Induced Morphologic Change | Status: RECRUITING